The Past, Present, and Future in Management of Small Renal Masses

Area of Science:

• Urology
• Oncology
• Radiology

Background:

• Increased incidence of small renal masses (SRMs) detected by cross-sectional imaging presents diagnostic and management challenges.
• Early diagnosis offers potential for high cure rates but risks overtreatment.
• Frequent updates in consensus guidelines and treatment modalities necessitate a comprehensive review.

Purpose of the Study:

• To summarize current information on the management of small renal masses.
• To detail historical and innovative treatments for renal cell carcinoma.
• To evaluate the role of biopsy, ablative techniques, active surveillance, and biomarkers in managing SRMs.

Main Methods:

• Review of current literature and guidelines on small renal mass management.
• Analysis of historical surgical treatments and contemporary innovations.
• Evaluation of the feasibility and utility of renal mass biopsy.
• Assessment of the efficacy of ablative techniques and active surveillance protocols.
• Exploration of the role of biomarkers in small renal mass diagnosis and management.

Main Results:

• Management of SRMs is evolving with new technologies and treatment options.
• Biopsy, ablative therapies, and active surveillance are increasingly utilized alongside surgical options.
• Biomarkers show potential for improved diagnostic accuracy and treatment selection.
• Technological advancements aim to reduce morbidity and overtreatment rates.

Conclusions:

• A multidisciplinary approach integrating novel technologies and treatment strategies is crucial for optimal small renal mass management.
• Balancing the benefits of early detection with the risks of overtreatment requires careful consideration of individual patient factors and emerging evidence.
• Continued research into biomarkers and minimally invasive techniques will further refine SRM care.